There was no direct question on that. But their confidence on maintaining at least $ 190-200 million base US business did, in a way indicate that their portfolio is not facing too many pressures
Plus the drug shortages in US are at 10 yr high. So …maybe we can take a leap of faith here
| Subscribe To Our Free Newsletter |
